MOESM2 of IL-2RÎą up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma

Additional file 2: Figure S2. Positron emission tomography-computed tomography of a 42-year-old man with refractory NKTCL before and after treatment with anti-IL-2RÎą antibody (basiliximab) and pegaspargase. Before treatment, diffuse infiltration of lymphoma with high metabolic activity was observed (right panel). After two cycles of treatment, partial remission was observed (left panel).